AV Therapeutics Announces Collaboration With DavosPharma to Manufacture Chemotherapeutic Drug Capridine
2/5/2014 9:41:31 AM
NEW YORK, Feb. 5, 2014 (GLOBE NEWSWIRE) -- AV Therapeutics, Inc., ("AV Therapeutics" or "the Company") (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, today announced that it has entered into an agreement with DavosPharma, a New Jersey-based company with 40 years of experience manufacturing drugs for the biotech industry, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine.
Help employers find you! Check out all the jobs and post your resume.
comments powered by